Risk Factors and Biomarkers for Diagnosis and Treatment of EoE

Active, not recruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Eosinophilic Esophagitis
Interventions
OTHER

Specimen Collection

Blood collection, possible saliva collection, possible urine collection, and biopsy collection

OTHER

Questionnaires

Subjects will complete a questionnaire utilizing validated symptom-specific instruments (Mayo Dysphagia Scale; GERD-HRQL Scale). The questionnaire will also record patient demographics, medical history, and current and past medication use

Trial Locations (1)

27599

University of North Carolina, Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT01988285 - Risk Factors and Biomarkers for Diagnosis and Treatment of EoE | Biotech Hunter | Biotech Hunter